PD
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Life After a Breast, Prostate or Colorectal Cancer: The Experience of Swiss Survivors | Cancer care research online | 2025 | 3 | 7 | |||
| Domains and categories of needs in long-term follow-up of adult cancer survivors : a scoping review of systematic reviews | Healthcare | 2024 | 94 | 221 | |||
| Experiences and Needs of Swiss Cancer Survivors in the Domains of Health-Related Information and the Healthcare System | Cancers | 2024 | 93 | 215 | |||
| Brain Metastases from Genito-Urinary Cancers in the Canton of Geneva (Switzerland) : Study of Incidence, Management and Outcomes | Cancers | 2024 | 87 | 140 | |||
| Identifying the drivers of overall rating of cancer care: Insights from the second wave of the Swiss Cancer Patient Experiences study | Cancer | 2024 | 162 | 145 | |||
| Neoantigen-specific T-cell response after donor lymphocyte infusion associates with favorable outcome in a patient with i(12p) germ cell tumor, acute leukemia and sarcoma of the same clonal origin | Haematologica | 2024 | 102 | 83 | |||
| Characteristics of long-survivor metastatic melanoma after polychemotherapy and interferon : a retrospective study | Swiss medical weekly | 2023 | 61 | 52 | |||
| Clonal expansion of intra-epithelial T cells in breast cancer revealed by spatial transcriptomics | International journal of cancer | 2023 | 510 | 89 | |||
| Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma | Cell death and disease | 2023 | 323 | 140 | |||
| Cancer vaccines | Cancer cell | 2022 | 311 | 177 | |||
| Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancer | BMC cancer | 2022 | 255 | 198 | |||
| The probabilistic model of Alzheimer disease: the amyloid hypothesis revised | Nature reviews. Neuroscience | 2022 | 166 | 1 | |||
| Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancer | iScience | 2022 | 240 | 167 | |||
| Hyaline cartilage microtissues engineered from adult dedifferentiated chondrocytes: safety and role of WNT signaling | Stem cells translational medicine | 2022 | 449 | 191 | |||
| Linking unfolded protein response to ovarian cancer cell fusion | BMC cancer | 2022 | 285 | 244 | |||
| The first comprehensive genomic characterization of rectal squamous cell carcinoma | Journal of gastroenterology | 2022 | 185 | 138 | |||
| Modeling poliovirus infection using human engineered neural tissue enriched with motor neuron derived from embryonic stem cells | Frontiers in Cell and Developmental Biology | 2021 | 369 | 166 | |||
| SARS-CoV-2 Evolution among Oncological Population: In-Depth Virological Analysis of a Clinical Cohort | Microorganisms | 2021 | 199 | 123 | |||
| Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy | Science Immunology | 2021 | 462 | 974 | |||
| Clonal Evolution of a High-Grade Pediatric Glioma With Distant Metastatic Spread | Neurology Genetics | 2021 | 333 | 94 | |||
| Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer | Cancer Cell | 2021 | 291 | 370 | |||
| Treating ICB-resistant glioma with anti-CD40 and mitotic spindle checkpoint controller BAL101553 (lisavanbulin) | JCI insight | 2021 | 263 | 178 | |||
| Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells | Communications Biology | 2021 | 343 | 207 | |||
| Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm? | Cancer treatment reviews | 2021 | 72 | 139 | |||
| Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment | Molecular Oncology | 2020 | 439 | 185 | |||
| An experimentally defined hypoxia gene signature in glioblastoma and its modulation by metformin | Biology (Basel)[2079-7737] | 2020 | 483 | 307 | |||
| Journée du cancer : mobiliser autour de la prévention | Revue médicale suisse | 2020 | 237 | 151 | |||
| Immunologic clearance of a BK virus-associated metastatic renal allograft carcinoma | Transplantation | 2020 | 345 | 358 | |||
| Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma | OncoImmunology | 2020 | 458 | 299 | |||
| Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma Patients | Frontiers in Oncology | 2020 | 352 | 152 | |||
| Oncologie : naviguer la pandémie de COVID-19 et garder le cap | Revue médicale suisse | 2020 | 259 | 141 | |||
| Describing adverse events in Swiss hospitalized oncology patients using the Global Trigger Tool | Health Science Reports | 2020 | 213 | 231 | |||
| Une période de craintes et de défis : vers un monde meilleur ? | Revue médicale suisse | 2020 | 207 | 0 | |||
| Stratégies de vaccination thérapeutique dans le glioblastome | Medecine Sciences | 2020 | 215 | 396 | |||
| Resources-stratified guidelines for classical hodgkin lymphoma | International Journal of Environmental Research and Public Health | 2020 | 411 | 348 | |||
| Patient-Derived In Vitro Models for Drug Discovery in Colorectal Carcinoma | Cancers | 2020 | 343 | 277 | |||
| Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma | Molecular and Cellular Proteomics | 2019 | 437 | 2 | |||
| De sérieuses préoccupations qui ne cachent pas nos espoirs | Revue médicale suisse | 2019 | 294 | 135 | |||
| Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients | Neuro-Oncology | 2019 | 848 | 601 | |||
| Current strategies for vaccination in glioblastoma | Current Opinion in Oncology | 2019 | 400 | 5 | |||
| Peptides as cancer vaccines | Current Opinion in Pharmacology | 2019 | 424 | 4 | |||
| Actively personalized vaccination trial for newly diagnosed glioblastoma | Nature | 2019 | 565 | 12 | |||
| Exploratory study of the effect of IMA950/poly-ICLC vaccination on response to bevacizumab in relapsing high-grade glioma patients | Cancers | 2019 | 370 | 206 | |||
| Prospective validation in epithelial tumors of a gene expression predictor of liver metastasis derived from uveal melanoma | Scientific Reports | 2019 | 275 | 825 | |||
| Prophylactic Cranial Irradiation in Stage III Non-Small-Cell Lung Cancer: Overall Survival Should Not Necessarily Be the Final End Point | Journal of Clinical Oncology | 2018 | 502 | 1 | |||
| CAR T-Cell Therapies in Glioblastoma: A First Look | Clinical Cancer Research | 2018 | 595 | 2 | |||
| Onco-sexologie : un regard au cœur des patients | Revue médicale suisse | 2018 | 295 | 166 | |||
| De vrais espoirs et de sérieuses préoccupations | Revue médicale suisse | 2018 | 336 | 2 | |||
| Learning from the past to design better trials in second-line treatment for mesothelioma patients | Ecancermedicalscience | 2018 | 360 | 134 | |||
| Médecine sexuelle et cancers : une main tendue vers l'humain | Revue médicale suisse | 2018 | 369 | 214 | |||
| Diagnosis and treatment of follicular lymphoma: an update | Swiss Medical Weekly | 2018 | 604 | 508 | |||
| Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors | The Journal of Pathology | 2018 | 889 | 6 | |||
| [Retracted] Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma | Molecular and Cellular Proteomics | 2018 | 442 | 9 | |||
| Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models | OncoImmunology | 2018 | 433 | 1 | |||
| Immune Checkpoint Inhibitor-Associated Myocarditis: A New Challenge for Cardiologists | Canadian Journal of Cardiology | 2018 | 533 | 2 | |||
| « Docteur, je jeûne lors de la chimiothérapie » : illusion ou nouvelle réalité clinique ? | Revue médicale suisse | 2018 | 635 | 707 | |||
| Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland | Swiss Medical Weekly | 2018 | 624 | 255 | |||
| Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma | OncoImmunology | 2018 | 665 | 363 | |||
| Prolonged Versus Short-Duration Use of Nasogastric Tubes in Patients with Head and Neck Cancer During Radiotherapy Alone or Combined Chemoradiotherapy | Nutrition and Cancer | 2018 | 485 | 483 | |||
| Prise en charge de la sexualité chez les patients oncologiques: Un projet de recherche au sein des Hôpitaux universitaires de Genève | Revue médicale suisse | 2018 | 408 | 295 | |||
| BRAF/MEK double blockade in refractory anaplastic pleomorphic xanthoastrocytoma | Neurology | 2017 | 547 | 223 | |||
| First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies | OncoImmunology | 2017 | 655 | 9 | |||
| A genetic polymorphism repurposes the G-protein coupled and membrane-associated estrogen receptor GPER to a transcription factor-like molecule promoting paracrine signaling between stroma and breast carcinoma cells | Oncotarget | 2017 | 535 | 220 | |||
| Les cancers s'envolent, les progrès suivent | Tribune de Geneve | 2017 | 384 | 80 | |||
| Immunothérapie des gliomes : illusion ou espoir ? | Bulletin du cancer | 2017 | 425 | 0 | |||
| Early closure of fistula using neo-adjuvant intra-arterial chemotherapy in locally advanced anal cancer | Digestive and Liver Disease | 2017 | 528 | 0 | |||
| Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial | The Lancet Oncology | 2017 | 426 | 1 | |||
| Identification of a novel population of highly cytotoxic c-Met-expressing CD8(+) T lymphocytes | EMBO Reports | 2017 | 597 | 4 | |||
| ER-mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem-like cells | EMBO Journal | 2017 | 622 | 10 | |||
| 8th Santorini Conference: Systems medicine and personalized health and therapy, Santorini, Greece, 3-5 October 2016 | Drug Metabolism and Personalized Therapy | 2017 | 576 | 3 | |||
| Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients | British Journal of Haematology | 2017 | 460 | 0 | |||
| Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma | Cancer Cell | 2017 | 515 | 5 | |||
| L'accès à l'innovation | Revue médicale suisse | 2017 | 343 | 0 | |||
| Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites? | Frontiers in Oncology | 2016 | 534 | 458 | |||
| Human tissue engineering allows the identification of active miRNA regulators of glioblastoma aggressiveness | Biomaterials | 2016 | 564 | 5 | |||
| Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes | Journal of neuro-oncology | 2016 | 525 | 563 | |||
| Outcome of patients with nonmetastatic muscle-invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin-based chemotherapy and/or radiotherapy: a retrospective analysis | Cancer medicine | 2016 | 581 | 247 | |||
| Cell-penetrating peptides-the Swiss Army knife of cancer vaccines | Oncoimmunology | 2016 | 650 | 336 | |||
| Progrès dans l'immunothérapie des tumeurs cérébrales : difficultés et perspectives | Revue médicale suisse | 2016 | 350 | 2 | |||
| Medulloblastoma in children and adults: one distinct disease entity? | Bulletin suisse du cancer | 2016 | 507 | 67 | |||
| Hypoxia and antitumor CD8(+) T cells: An incompatible alliance? | OncoImmunology | 2016 | 489 | 356 | |||
| Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing | PloS one | 2016 | 669 | 676 | |||
| Ipilimumab-related hypophysitis may precede severe CNS immune attack | Annals of Oncology | 2016 | 459 | 0 | |||
| Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants | Molecular therapy | 2016 | 678 | 355 | |||
| Chimiothérapie de maintenance : futile ou utile ? | Revue médicale suisse | 2015 | 484 | 212 | |||
| Aggressiveness of cancer treatment in patients hospitalized in a supportive care unit | Supportive care in cancer | 2015 | 686 | 1 | |||
| Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells | European Journal of Immunology | 2015 | 553 | 7 | |||
| Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review | CNS oncology | 2015 | 509 | 0 | |||
| Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor Immunity | Cancer research | 2015 | 644 | 10 | |||
| La société face au cancer : prises de conscience et initiatives citoyennes | Revue médicale suisse | 2015 | 381 | 78 | |||
| Lymphome cérébral : une présentation classique ? | Revue médicale suisse | 2015 | 396 | 535 | |||
| Immunotherapy of Brain Tumors | Progress in tumor research | 2015 | 586 | 0 | |||
| Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome | Annals of oncology | 2015 | 482 | 211 | |||
| Création du Centre du cancer de la prostate des HUG | Revue médicale suisse | 2014 | 758 | 2 | |||
| Immunotherapy for glioma: from illusion to realistic prospects? | American Society of Clinical Oncology educational book | 2014 | 1,276 | 641 | |||
| Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma | British journal of cancer | 2014 | 666 | 194 | |||
| Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral-like type I interferon gene response | International journal of cancer | 2014 | 752 | 486 | |||
| Extrachromosomal driver mutations in glioblastoma and low-grade glioma | Nature communications | 2014 | 771 | 251 | |||
| Fine-needle aspiration biopsy for the diagnosis of metastatic type B thymoma to lymph nodes: A case report | Diagnostic cytopathology | 2014 | 623 | 0 | |||
| Injecting hope into brain cancer treatment: is immunotherapy the way forward? | CNS Oncology | 2014 | 403 | 0 | |||
| Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08) | European urology | 2013 | 603 | 0 | |||
| Radioimmunotherapy combined with maintenance anti-CD20 antibody may trigger long-term protective T cell immunity in follicular lymphoma patients | Clinical & developmental immunology | 2013 | 646 | 591 | |||
| Neuropathies associées aux paraprotéinémies (gammapathies monoclonales) | Revue médicale suisse | 2013 | 455 | 0 | |||
| Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumours | PloS one | 2013 | 731 | 333 | |||
| The relationship between brain tumor cell invasion of engineered neural tissues and in vivo features of glioblastoma | Biomaterials | 2013 | 737 | 6 | |||
| Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy | Journal of neuro-oncology | 2013 | 688 | 0 | |||
| Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies | Immunotherapy | 2013 | 546 | 0 | |||
| Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival | Nature medicine | 2012 | 585 | 2 | |||
| MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status | Acta neuropathologica | 2012 | 608 | 1,089 | |||
| Plasmablastic lymphoma clinically presenting in the urinary tract | Annals of diagnostic pathology | 2012 | 669 | 0 | |||
| A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma | Haematologica | 2012 | 639 | 479 | |||
| Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy | Brain | 2012 | 709 | 1,463 | |||
| Complete remission with tyrosine kinase inhibitors in renal cell carcinoma | Journal of clinical oncology | 2012 | 763 | 819 | |||
| Visceral Kaposi's Sarcoma Related to Human Herpesvirus-8 in Liver Transplant Recipient: Case Report and Literature Review | Case reports in oncological medicine | 2012 | 640 | 320 | |||
| Takotsubo syndrome secondary to adrenal adenocarcinoma: cortisol as a possible culprit | American journal of respiratory and critical care medicine | 2012 | 661 | 5 | |||
| A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients | The oncologist | 2012 | 693 | 0 | |||
| Delayed but Complete Response following Oral Temozolomide Treatment in Melanoma Leptomeningeal Carcinomatosis | Case reports in oncology | 2011 | 655 | 0 | |||
| Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients | Haematologica | 2011 | 1,053 | 635 | |||
| Soin nutritionnel intégré au soin oncologique : un besoin d'optimisation | Revue médicale suisse | 2011 | 988 | 846 | |||
| Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study | Arthritis and rheumatism | 2011 | 879 | 8 | |||
| Prevention of CNS relapse in diffuse large B-cell lymphoma | Lancet oncology | 2011 | 570 | 0 | |||
| Recurrent Syncope due to Esophageal Squamous Cell Carcinoma | Case reports in oncology | 2011 | 694 | 306 | |||
| Gastrointestinal relapse of multiple myeloma and sustained response to lenalidomide: a case report | Journal of medical case reports | 2011 | 623 | 179 | |||
| Oncology ESAB 2011 | 2011 | 683 | 10 | ||||
| Cooperative expression of junctional adhesion molecule-C and -B supports growth and invasion of glioma | GLIA | 2010 | 686 | 0 | |||
| [Retracted] Marker-independent identification of glioma-initiating cells | Nature methods | 2010 | 544 | 0 | |||
| Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98 | Journal of clinical oncology | 2010 | 555 | 0 | |||
| Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor development | Cancer research | 2010 | 620 | 3 | |||
| T-cell immunotherapy for malignant glioma: toward a combined approach | Current opinion in oncology | 2010 | 666 | 2 | |||
| Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma | Journal of clinical oncology | 2010 | 627 | 0 | |||
| Tumors that look for their springtime in APRIL | Critical reviews in oncology/hematology | 2009 | 660 | 0 | |||
| Limits of CD133 as a marker of glioma self-renewing cells | International journal of cancer | 2009 | 645 | 0 | |||
| Vaccination of melanoma patients with Melan-A/Mart-1 peptide and Klebsiella outer membrane protein p40 as an adjuvant | Journal of immunotherapy | 2009 | 618 | 0 | |||
| Diagnostic precision of image-guided multisampling core needle biopsy of suspected lymphomas in a primary care hospital | British journal of cancer | 2009 | 703 | 0 | |||
| Intrathecal MTX for DLBCL: from an inappropriate prophylactic tradition to a medical error? | Blood | 2009 | 549 | 1 | |||
| Generalized xerotic dermatitis with neutrophilic spongiosis induced by erlotinib (Tarceva) | Dermatology | 2008 | 545 | 0 | |||
| Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma | Journal of clinical oncology | 2008 | 697 | 0 | |||
| Bevacizumab/Irinotecan. Un nouveau traitement actif dans les gliomes de haut grade récidivants : résultats préliminaires d'une étude multicentrique de l'Anocef | Revue neurologique | 2008 | 687 | 0 | |||
| Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome | Annals of oncology | 2008 | 593 | 0 | |||
| Percutaneous cementoplasty in multiple myeloma: a valuable adjunct for pain control and ambulation maintenance | Supportive care in cancer | 2008 | 649 | 306 | |||
| Peripheral tolerance limits CNS accumulation of CD8 T cells specific for an antigen shared by tumor cells and normal astrocytes | GLIA | 2008 | 663 | 11 | |||
| Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers | Annals of oncology | 2008 | 541 | 0 | |||
| Management of malignant pleural effusion and ascites by a triple access multi perforated large diameter catheter port system | World journal of surgical oncology | 2008 | 1,185 | 567 | |||
| Bortezomib-induced skin eruption | Dermatology | 2008 | 604 | 0 | |||
| Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas | Journal of pathology | 2006 | 648 | 0 | |||
| Cytomegalovirus colitis--a severe complication after standard chemotherapy | Acta oncologica | 2002 | 630 | 0 |
